查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1905022

全球智慧电网市场：按技术、应用和地区分析－市场规模、产业趋势、机会分析和预测（2026-2035）

Global FemTech Market: By Offering, Applications, Distribution Channel, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 256 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球智慧电网市场正经历强劲扩张期，反映出市场对能够应对现代电网挑战的先进能源系统的需求日益增长。 2025年，该市场规模将达到525.5亿美元，显示全球对智慧电网技术的投资庞大且应用广泛。预计未来十年，这一成长动能将显着加速，到2035年将达到2,591.5亿美元。这一成长轨迹意味着2026年至2035年预测期内的复合年增长率将高达17.30%，显示全球对升级电力基础设施的浓厚兴趣持续存在。

推动市场快速成长的关键因素很多。首要催化剂是迫切需要对老化的电力基础设施进行现代化改造。这些系统大多设计于几十年前，已无法满足当今不断变化的能源需求。现代化改造的重点在于用智慧系统取代过时的设备，以实现即时监控、自动化和数据驱动的决策。同时，风能、太阳能和分散式发电等再生能源的併网正在加速，这需要更智慧的电网解决方案来有效管理这些资源的间歇性和分散性。最后，人们越来越重视提高能源效率，并增强电网抵御极端天气、网路威胁和其他挑战造成的干扰的能力。

市场趋势

智慧电网市场的竞争格局明显有利于那些成功采用数位智慧和先进技术的成熟产业领导者。这些公司正在利用其丰富的经验和资源来满足对智慧电网解决方案的激增需求。目前，由于普遍存在的容量限制，需求超过了供应。这种供需失衡造成了前所未有的订单积压，既反映了公用事业公司和政府迫切需要对其电力基础设施进行现代化改造，也反映了製造商在快速扩大生产规模方面面临的挑战。

主要市场参与者包括西门子、施耐德电机、通用电气 (GE)、ABB、Itron 和 IBM 等全球性公司。这些公司利用其广泛的产品组合、技术专长和全球影响力，提供全面的智慧电网解决方案，以满足全球公用事业公司的多样化需求。除了这些行业巨头之外，专业技术供应商也发挥关键作用，他们提供的创新技术可以补充和增强领先企业的能力。

智慧电网发展的一个显着例子是摩洛哥于 2025 年 11 月启动了非洲首个智慧电网平台，这是确保该国能源未来的决定性一步。这项由国家电力和饮用水公司 (ONEE) 发起并于当月早些时候在电力科学技术中心宣布的开创性举措，标誌着非洲大陆能源转型工作取得了重大进展。本计画由非洲开发银行资助，投资额超过400万迪拉姆，不仅彰显了摩洛哥对永续能源的承诺，也巩固了摩洛哥在智慧电网创新领域的非洲大陆领先地位。

主要成长驱动因素

推动智慧电网市场快速成长的关键因素是风能和太阳能等可变再生能源的爆炸性成长。在环境问题和减少碳排放的政策要求的推动下，这些再生能源正处于全球向更清洁、更永续的能源系统转型努力的核心。然而，可变再生能源固有的间歇性和不可预测性给电网营运商带来了巨大挑战，他们必须即时平衡供需以维持电网的稳定性和可靠性。与提供稳定、可控输出的传统发电厂不同，再生能源会随天气状况波动，产生传统电网基础设施难以应对的复杂问题。

新机会趋势

人工智慧 (AI) 和气候韧性在重塑智慧电网市场方向方面发挥着日益重要的作用。随着电网变得日益复杂，尤其是在分散式能源兴起的情况下，电力公司正转向生成式人工智慧技术，以更有效地管理这种复杂性。人工智慧的应用正在蓬勃发展，因为这些先进的演算法为电力公司提供了强大的工具，用于优化电网运行、预测需求以及无缝整合各种能源。透过即时分析大量数据，人工智慧能够实现更智慧的决策，提高营运效率，并帮助电力公司主动应对电网中的波动和中断。

优化障碍

虽然智慧电网市场随着连接性和数位化整合的增强而不断发展，但也增加了遭受网路攻击的风险，为电力系统带来了重大风险。虽然提高设备、感测器和通讯网路之间的互联互通对于提高电网的效率和回应能力至关重要，但同时也扩大了恶意行为者的攻击面。网路威胁，包括破坏、欺骗和中间人攻击，正变得日益复杂，并瞄准电网基础设施的关键组件，扰乱运行、窃取敏感资料并造成大范围停电。

目录

第一章：摘要整理：全球智慧电网市场

第二章：研究方法与架构

  • 研究目标
  • 产品概述
  • 市场区隔
  • 质性研究
    • 一手和二手资料来源
  • 量化研究
    • 一手和二手资料来源
  • 按地区划分的主要调查受访者组成
  • 研究假设
  • 市场规模估算
  • 数据三角测量法

第三章 全球智慧电网市场概述

  • 产业价值链分析
    • 原料供应商
    • 製造商
    • 经销商
    • 终端用户
  • 行业展望
    • 全球电力生产
    • 全球电力消费
  • PESTLE分析
  • 波特五力分析
    • 供应商议价能力
    • 买方议价能力
    • 替代品威胁
    • 新进入者威胁
    • 竞争强度
  • 市场成长与展望
    • 市场收入估计与预测（2020-2035）
    • 价格趋势分析技术
  • 市场吸引力分析
    • 依技术分类
    • 依地区分类
  • 可操作的洞见（分析师建议）

第四章：竞争格局概览

  • 市场集中度
  • 公司占有率分析（基于价值，2025 年）
  • 竞争格局分析与基准分析

第五章：全球智慧电网市场分析

  • 市场动态与趋势
    • 成长驱动因素
    • 限制因素
    • 机遇
    • 关键趋势
  • 市场规模及预测（2020-2035 年）
    • 按技术
      • 进阶计量基础设施 (AMI)
      • 配电管理
      • 变电站自动化
      • 通信
      • 安全
      • 网路管理
    • 按应用领域划分
      • 发电
      • 输电
      • 配电
      • 用电
    • 按地区划分

第六章：北美智慧电网市场分析

第七章：欧洲智慧电网市场分析

第八章：亚太地区智慧电网市场分析

第九章：中东与非洲智慧电网市场分析

第十章：南美洲智慧电网市场分析

第十一章：公司公司简介

  • ABB
  • Aclara
  • 思科
  • 伊顿
  • 通用电气
  • 霍尼韦尔
  • IBM
  • Itron
  • 兰吉尔
  • 甲骨文
  • S&C电气公司
  • 施耐德电机
  • 西门子
  • 威普罗有限公司
  • 其他主要参与者

第十二章：附录

简介目录
Product Code: AA0124751

The FemTech (Female Technology) market, which centers on digital solutions designed to address women's health needs, is undergoing remarkable expansion. Valued at approximately US$ 63.14 billion in 2025, the market is projected to reach an impressive valuation of US$ 266.99 billion by 2035. This forecasted growth represents a robust compound annual growth rate (CAGR) of 15.51% durimg the period from 2026 to 2035, signaling a rapidly evolving and increasingly vital sector within the broader healthcare technology landscape. The surge in market value reflects both the expanding recognition of women's unique health requirements and the rising integration of advanced technologies that cater specifically to those needs.

Several key factors are driving this accelerated growth in the FemTech market. One of the primary catalysts is the increasing awareness around women's health issues, which has helped break down traditional stigmas and promote more open discussions. As public understanding improves, more women are actively seeking solutions that address their specific health concerns, ranging from reproductive health to menstrual care, sexual wellness, and broader general health management. This growing awareness fuels demand not only for products but also for services that can provide meaningful support and empowerment in managing health.

Noteworthy Market Developments

The competitive hierarchy within the FemTech market has increasingly solidified around players who have successfully integrated clinical efficacy with consumer-friendly technology, creating a new benchmark for success in the industry. Competition is no longer confined to emerging startups alone; it now spans a broader spectrum where nimble startups face off against established legacy healthcare institutions. This evolving dynamic is shaped by the fact that hospitals and maternal centers continue to command a substantial 46.54% share of the market's revenue, underscoring their enduring influence and the trust they hold within the healthcare ecosystem.

Recent developments illustrate the intensity and diversity of competition in this space. In January 2026, OTO Fertility, a division of the Canada-based company OTO Coach, launched a groundbreaking platform that combines a clinical-grade wearable biosensor with an FDA-approved application designed to predict fertility treatment outcomes. This innovation exemplifies how startups are leveraging advanced technology and regulatory validation to offer clinically robust solutions directly to consumers. Meanwhile, in December 2025, Ovum and AKQA announced a strategic partnership aimed at accelerating AI-powered women's health innovation.

Further reflecting the competitive vibrancy of the market, November 2025 saw IdentifyHer open US pre-orders for Peri, a wearable device specifically designed to detect and track perimenopause symptoms. This product addresses a critical and often underrepresented segment of women's health, highlighting the growing focus on personalized monitoring and symptom management during transitional life stages. In the same month, Bristol-based startup Emm successfully raised £6.8 million in an oversubscribed seed funding round to bring the world's first smart menstrual cup and connected app to market.

Core Growth Drivers

Increasing awareness and growing demand are key forces propelling the FemTech market forward, fueling its rapid expansion and shaping its future trajectory. Over recent years, there has been a marked shift in societal attitudes toward women's health, with more open discussions and education helping to break down long-standing taboos. This heightened awareness has empowered women to prioritize their health and seek out innovative solutions tailored specifically to their unique needs. As a result, more women are becoming informed about the availability and benefits of FemTech products and services, leading to a significant increase in consumer interest and willingness to adopt these technologies.

Emerging Opportunity Trends

Technological advancements and improved access are emerging as powerful catalysts driving the adoption of FemTech solutions, presenting a significant opportunity for market growth. Rapid innovation in areas such as artificial intelligence, wearable sensors, mobile health applications, and telemedicine has transformed the landscape of women's healthcare, making it more personalized, accessible, and efficient. These cutting-edge technologies enable FemTech products to offer real-time monitoring, predictive analytics, and tailored health recommendations, which greatly enhance user engagement and health outcomes. As a result, women are increasingly empowered to take control of their health journeys with tools that are both convenient and clinically reliable.

Barriers to Optimization

Persistent social stigma surrounding women's health continues to pose a significant barrier to the growth of the FemTech market. Despite increasing awareness and progressive conversations around women's health issues, many topics remain taboo or uncomfortable to discuss openly in various cultures and communities worldwide. This stigma often discourages women from seeking timely medical advice, utilizing health technologies, or purchasing products related to sensitive areas such as menstruation, fertility, sexual health, and menopause. As a result, the market faces challenges in reaching a broader audience and fully unlocking the potential demand for FemTech solutions.

Detailed Market Segmentation

By Offerings, the FemTech equipment segment holds a dominant position in the overall FemTech market, commanding a substantial 45.46% share of total revenue. This dominance is largely due to the high unit cost associated with medical-grade hardware, which naturally contributes to larger revenue figures compared to software or service-based offerings. More importantly, the market is witnessing a significant shift toward clinical-grade home care, where consumers increasingly seek reliable, professional-level devices that can be used conveniently in the comfort of their own homes. This trend reflects a broader movement in healthcare toward decentralization and personalized care, where patients are empowered with sophisticated tools to monitor and manage their health outside of traditional clinical settings.

By Application, the pregnancy and nursing segment commands a substantial 30.98% share of the FemTech market, reflecting its critical role in addressing one of the most medically intensive and emotionally significant periods in a woman's life. This phase involves heightened healthcare needs and complexities, making it a focal point for technological innovation and specialized medical support. Women during pregnancy and nursing are often highly motivated to invest in products and services that provide safety, comfort, and reassurance, which drives a strong willingness to pay. This financial commitment is further amplified by increasing awareness of maternal health risks, prompting demand for advanced monitoring and care solutions that can help mitigate complications and ensure the well-being of both mother and child.

By Distribution Channel, Retail channels play a pivotal role in the women's health market, contributing a significant 51.85% of the total revenue. This strong performance is fueled by the growing mainstream destigmatization of women's health issues, which has encouraged more open conversations and acceptance around topics that were once considered taboo. As a result, a wider demographic of consumers feels comfortable seeking out and purchasing health products through traditional retail outlets. This cultural shift has been instrumental in driving more traffic to physical stores and legitimizing retail channels as trusted sources for women's health solutions.

Segment Breakdown

By Offering

  • Equipment
  • Fertility Tracker
  • Breast Feeding Pumps
  • Monitoring Devices
  • Pregnancy and Ovulation Testing Kits
  • Wearables
  • Others
  • Digital Platforms/Applications
  • Consumables
  • Therapeutic Drugs
  • Vitamins & Supplements
  • Others
  • Services

By Application

  • Reproductive Health & Contraception
  • Pregnancy & Nursing
  • Menstrual Health
  • Mental Health
  • General Health & Wellness
  • Others

By Distribution Channel

  • Retail
  • Online

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America continues to dominate the global FemTech market, firmly establishing itself as the undisputed heavyweight with a commanding 38.64% share of the total market in 2024. This dominant position is largely driven by the United States, which alone accounts for an impressive 89.2% of the region's total revenue. The strength of the North American FemTech market can be attributed to several unique factors, including the region's innovative approach to healthcare benefits, corporate culture, and early adoption of technology-driven solutions aimed at women's health.
  • A key element underpinning this dominance is the distinctive "employer-pay" model prevalent in North America, particularly in the U.S. In this model, companies proactively offer comprehensive fertility and menopause-related benefits as part of their employee wellness programs. This approach is motivated by a growing recognition that supporting women's health is essential for talent retention and workforce productivity. Employers view investments in FemTech solutions not only as a way to enhance employee well-being but also as a strategic tool to attract and retain top talent in competitive industries.

Leading Market Participants

  • Ava Sciences
  • Baymatob Operations Pty. Ltd
  • Bonzun
  • Carrot
  • Chiaro Technology Limited (Elvie)
  • Clue (Biowink GmbH)
  • Flo Health
  • Glow Inc.
  • Kindbody (KBI Services, Inc.)
  • Maven Clinic
  • Natural Cycles
  • RO Health Inc.
  • Willow Innovations, Inc
  • Other Prominent Players

Table of Content

Chapter 1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

Chapter 2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
  • 2.4. Assumption for the Study
  • 2.5. Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global FemTech Market

Chapter 4. Global FemTech Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Service Provider
    • 4.1.2. End User
  • 4.2. Industry Outlook
    • 4.2.1. Overview of FemTech Industry Development
    • 4.2.2. Overview on FemTech Investment
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Market Dynamics and Trends
    • 4.5.1. Growth Drivers
      • 4.5.1.1. The rise of VC funding for FemTech
    • 4.5.2. Restraints
    • 4.5.3. Challenges
    • 4.5.4. Key Trends
  • 4.6. Covid-19 Impact Assessment on Market Growth Trend
  • 4.7. Market Growth and Outlook
    • 4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2020 - 2035
  • 4.8. Competition Dashboard
    • 4.8.1. Market Concentration Rate
    • 4.8.2. Company Market Share Analysis (Value %), 2025
    • 4.8.3. Competitor Mapping

Chapter 5. Global FemTech Market Analysis, By Offering

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
    • 5.2.1. Equipment
      • 5.2.1.1. Fertility Tracker
      • 5.2.1.2. Breast Feeding Pumps
      • 5.2.1.3. Monitoring Devices
      • 5.2.1.4. Pregnancy and Ovulation Testing Kits
      • 5.2.1.5. Wearables
      • 5.2.1.6. Others
    • 5.2.2. Digital Platforms/Applications
    • 5.2.3. Consumables
      • 5.2.3.1. Therapeutic Drugs
      • 5.2.3.2. Vitamins & Supplements
      • 5.2.3.3. Others
    • 5.2.4. Services

Chapter 6. Global FemTech Market Analysis, By Application

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
    • 6.2.1. Reproductive Health & Contraception
    • 6.2.2. Pregnancy & Nursing
    • 6.2.3. Menstrual Health
    • 6.2.4. Mental Health
    • 6.2.5. General Health & Wellness
    • 6.2.6. Others

Chapter 7. Global FemTech Market Analysis, By Distribution Channel

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
    • 7.2.1. Retail
    • 7.2.2. Online

Chapter 8. Global FemTech Market Analysis, By Region

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
    • 8.2.1. North America
      • 8.2.1.1. The U.S.
      • 8.2.1.2. Canada
      • 8.2.1.3. Mexico
    • 8.2.2. Europe
      • 8.2.2.1. Western Europe
        • 8.2.2.1.1. The UK
        • 8.2.2.1.2. Germany
        • 8.2.2.1.3. France
        • 8.2.2.1.4. Italy
        • 8.2.2.1.5. Spain
        • 8.2.2.1.6. Rest of Western Europe
      • 8.2.2.2. Eastern Europe
        • 8.2.2.2.1. Poland
        • 8.2.2.2.2. Russia
        • 8.2.2.2.3. Rest of Eastern Europe
    • 8.2.3. Asia Pacific
      • 8.2.3.1. China
      • 8.2.3.2. India
      • 8.2.3.3. Japan
      • 8.2.3.4. South Korea
      • 8.2.3.5. Australia & New Zealand
      • 8.2.3.6. ASEAN
      • 8.2.3.7. Rest of Asia Pacific
    • 8.2.4. Middle East & Africa
      • 8.2.4.1. UAE
      • 8.2.4.2. Saudi Arabia
      • 8.2.4.3. South Africa
      • 8.2.4.4. Rest of MEA
    • 8.2.5. South America
      • 8.2.5.1. Argentina
      • 8.2.5.2. Brazil
      • 8.2.5.3. Rest of South America

Chapter 9. North America FemTech Market Analysis

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
    • 9.2.1. By Offering
    • 9.2.2. By Application
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country

Chapter 10. Europe FemTech Market Analysis

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
    • 10.2.1. By Offering
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country

Chapter 11. Asia Pacific FemTech Market Analysis

  • 11.1. Key Insights
  • 11.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
    • 11.2.1. By Offering
    • 11.2.2. By Application
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country

Chapter 12. Middle East and Africa FemTech Market Analysis

  • 12.1. Key Insights
  • 12.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
    • 12.2.1. By Offering
    • 12.2.2. By Application
    • 12.2.3. By Distribution Channel
    • 12.2.4. By Country

Chapter 13. South America FemTech Market Analysis

  • 13.1. Key Insights
  • 13.2. Market Size and Forecast, 2020 - 2035 (US$ Bn)
    • 13.2.1. By Offering
    • 13.2.2. By Application
    • 13.2.3. By Distribution Channel
    • 13.2.4. By Country

Chapter 14. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 14.1. Ava Sciences
  • 14.2. Baymatob Operations Pty. Ltd
  • 14.3. Bonzun
  • 14.4. Carrot
  • 14.5. Chiaro Technology Limited (Elvie)
  • 14.6. Clue (Biowink GmbH)
  • 14.7. Flo Health
  • 14.8. Glow Inc.
  • 14.9. Kindbody (KBI Services, Inc.)
  • 14.10. Maven Clinic
  • 14.11. Natural Cycles
  • 14.12. RO Health Inc.
  • 14.13. Willow Innovations, Inc
  • 14.14. Other Prominent Players